These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33466200)

  • 21. Outcome and safety assessment of an herbal medicine treatment protocol for yin pattern of acute ischemic stroke.
    Huang Y; Guo JW;
    Zhong Xi Yi Jie He Xue Bao; 2010 May; 8(5):417-26. PubMed ID: 20456839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.
    Hacke W; Furlan AJ; Al-Rawi Y; Davalos A; Fiebach JB; Gruber F; Kaste M; Lipka LJ; Pedraza S; Ringleb PA; Rowley HA; Schneider D; Schwamm LH; Leal JS; Söhngen M; Teal PA; Wilhelm-Ogunbiyi K; Wintermark M; Warach S
    Lancet Neurol; 2009 Feb; 8(2):141-50. PubMed ID: 19097942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chinese medicine NeuroAiD efficacy stroke recovery-extension study (CHIMES-E study): an observational multicenter study to investigate the longer-term efficacy of NeuroAiD in stroke recovery.
    Venketasubramanian N; Young S; Tay SS; Chang HM; Umapathi T; Chan B; de Silva A; Wong L; Navarro J; Zhao YD; Tan SB; Chen C
    Cerebrovasc Dis; 2013; 35 Suppl 1():18-22. PubMed ID: 23548915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine low-dose continuous or nocturnal oxygen for people with acute stroke: three-arm Stroke Oxygen Supplementation RCT.
    Roffe C; Nevatte T; Bishop J; Sim J; Penaloza C; Jowett S; Ives N; Gray R; Ferdinand P; Muddegowda G
    Health Technol Assess; 2018 Mar; 22(14):1-88. PubMed ID: 29595449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale and Design of a Randomized, Double-Blind Trial Evaluating the Efficacy of Tranexamic Acid on Hematoma Expansion and Peri-hematomal Edema in Patients with Spontaneous Intracerebral Hemorrhage within 4.5 h after Symptom Onset: The THE-ICH Trial Protocol.
    Jiang C; Wang J; Wang J; Zhang J;
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105136. PubMed ID: 32912508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized controlled trial for gualou danshen granules in the treatment of unstable angina pectoris patients with phlegm-blood stasis syndrome.
    Guo J; Dai S; Ding Y; He H; Zhang H; Dan W; Qin K; Wang H; Li A; Meng P; Li S; He Q
    Medicine (Baltimore); 2020 Aug; 99(33):e21593. PubMed ID: 32872012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).
    Adams HP; Effron MB; Torner J; Dávalos A; Frayne J; Teal P; Leclerc J; Oemar B; Padgett L; Barnathan ES; Hacke W;
    Stroke; 2008 Jan; 39(1):87-99. PubMed ID: 18032739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial.
    Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW;
    Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.
    Lyden PD; Shuaib A; Lees KR; Davalos A; Davis SM; Diener HC; Grotta JC; Ashwood TJ; Hardemark HG; Svensson HH; Rodichok L; Wasiewski WW; Ahlberg G;
    Stroke; 2007 Aug; 38(8):2262-9. PubMed ID: 17569876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of the Efficacy of Huoxue Huayu Method Combined With Conventional Western Medicine in the Treatment of Hydrocephalus After Cerebral Hemorrhage.
    Luo L; Li M; Wan X; Lu Y; Yu X
    Altern Ther Health Med; 2023 Sep; 29(6):300-305. PubMed ID: 37318895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.
    Sandset EC; Bath PM; Boysen G; Jatuzis D; Kõrv J; Lüders S; Murray GD; Richter PS; Roine RO; Terént A; Thijs V; Berge E;
    Lancet; 2011 Feb; 377(9767):741-50. PubMed ID: 21316752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xingnaojing for Moderate-to-severe Acute ischemic Stroke (XMAS): study protocol for a randomized controlled trial.
    Lai X; Cao K; Kong L; Liu Q; Gao Y;
    Trials; 2017 Oct; 18(1):479. PubMed ID: 29037226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of Y-2 sublingual tablet for patients with acute ischaemic stroke: protocol of a phase III randomised double-blind placebo-controlled multicentre trial.
    Fu Y; Tang R; Chen R; Wang A; Ren J; Zhu S; Feng X; Fan D
    Stroke Vasc Neurol; 2024 Feb; 9(1):90-95. PubMed ID: 37308251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.
    Donnan GA; Davis SM; Chambers BR; Gates PC; Hankey GJ; McNeil JJ; Rosen D; Stewart-Wynne EG; Tuck RR
    JAMA; 1996 Sep; 276(12):961-6. PubMed ID: 8805730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial.
    Wu QJ; Lv WL; Li JM; Zhang TT; Zhou WH; Zhang Q; Wang JC; Wang QN; Zhang RX; Zhao X; Chen ST; Liu S; Li GH; Cao ZM; Xu L; Chen J
    Trials; 2020 Jun; 21(1):482. PubMed ID: 32503608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC).
    Gonzales NR; Shah J; Sangha N; Sosa L; Martinez R; Shen L; Kasam M; Morales MM; Hossain MM; Barreto AD; Savitz SI; Lopez G; Misra V; Wu TC; El Khoury R; Sarraj A; Sahota P; Hicks W; Acosta I; Sline MR; Rahbar MH; Zhao X; Aronowski J; Grotta JC
    Int J Stroke; 2013 Jul; 8(5):388-96. PubMed ID: 22340518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease.
    Wang Y; Zhang Y; Du Y; Yang Y; Wei J; Zhang N; Mao M; Du W; Liu P
    Medicine (Baltimore); 2019 Nov; 98(44):e17753. PubMed ID: 31689832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of Chinese Drugs for Breaking Blood Expelling Stasis on Acute Cerebral Hemorrhage: a Prospective Randomized Double-blind Controlled Study].
    Xia ZY; Wang J; Guo JW; Zhang R; Li JX; Zhong JB; Luo SH; Chen GS; Huang G; Zhao QS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):821-826. PubMed ID: 30634209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between disability measures and short-term health care costs following intracerebral hemorrhage.
    Christensen MC; Morris S
    Neurocrit Care; 2008; 9(3):313-8. PubMed ID: 18696272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.